HK62889A - Sucralfate suspension - Google Patents

Sucralfate suspension Download PDF

Info

Publication number
HK62889A
HK62889A HK628/89A HK62889A HK62889A HK 62889 A HK62889 A HK 62889A HK 628/89 A HK628/89 A HK 628/89A HK 62889 A HK62889 A HK 62889A HK 62889 A HK62889 A HK 62889A
Authority
HK
Hong Kong
Prior art keywords
weight
xanthan gum
suspension
suspensions
sucralfate
Prior art date
Application number
HK628/89A
Other languages
German (de)
English (en)
Inventor
Ullrich Dr. Hanstein
Lothar Bauer
Original Assignee
Merck Patent Gesellschaft Mit Beschrankter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6243590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK62889(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gesellschaft Mit Beschrankter Haftung filed Critical Merck Patent Gesellschaft Mit Beschrankter Haftung
Publication of HK62889A publication Critical patent/HK62889A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Glass Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (4)

1. Compositions pharmaceutiques sous forme de suspensions contenant du Sucralfate, caractérisées en ce qu'elles contiennent, par rapport au Sucralfate, de 1 à 5% en poids de gomme de xanthane et de 1 à 12,5% en poids d'au moins un agent peptisant.
2. Compositions pharmaceutiques selon la revendication 1, caractérisées en ce que l'agent peptisant consiste en au moins un sel de l'acide phosphorique et/ou de l'acide citrique.
3. Compositions pharmaceutiques selon les revendications 1 ou 2, caractérisées en ce qu'elles contiennent, par rapport au poids total, de 1 à 40% en poids de Sucralfate.
4. Procédé pour stabiliser des compositions pharmaceutiques sous forme de suspensions contenant du Sucralfate, caractérisé en ce que l'on ajoute à ces compositions, par rapport à la teneur en Sucralfate, de 1 à 5% en poids de gomme de xanthane et de 1 à 12,5% en poids d'au moins un agent peptisant.
HK628/89A 1984-08-22 1989-08-03 Sucralfate suspension HK62889A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843430809 DE3430809A1 (de) 1984-08-22 1984-08-22 Sucralfat-suspension
PCT/EP1984/000294 WO1986001406A1 (fr) 1984-08-22 1984-09-22 Suspension de sucralfate

Publications (1)

Publication Number Publication Date
HK62889A true HK62889A (en) 1989-08-11

Family

ID=6243590

Family Applications (1)

Application Number Title Priority Date Filing Date
HK628/89A HK62889A (en) 1984-08-22 1989-08-03 Sucralfate suspension

Country Status (25)

Country Link
US (1) US4885281A (fr)
EP (1) EP0192640B1 (fr)
JP (1) JPS61503031A (fr)
CN (1) CN85109551A (fr)
AT (1) ATE41308T1 (fr)
AU (1) AU567257B2 (fr)
CA (1) CA1236773A (fr)
DE (2) DE3430809A1 (fr)
DK (1) DK164479C (fr)
ES (1) ES8607727A1 (fr)
FI (1) FI80592C (fr)
GR (1) GR852023B (fr)
HK (1) HK62889A (fr)
IE (1) IE58201B1 (fr)
IL (1) IL76138A (fr)
IN (1) IN164763B (fr)
IT (1) IT1178235B (fr)
NO (1) NO170126C (fr)
NZ (1) NZ213185A (fr)
PH (1) PH21250A (fr)
PT (1) PT79610A (fr)
SG (1) SG35889G (fr)
SU (1) SU1544173A3 (fr)
WO (1) WO1986001406A1 (fr)
ZA (1) ZA848884B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714159C2 (de) * 1986-04-30 1996-09-19 Chugai Pharmaceutical Co Ltd Sucralfat-Zubereitung
AU594765B2 (en) * 1986-05-16 1990-03-15 Chugai Seiyaku Kabushiki Kaisha Sucralfate preparations for applications on esophagus mucosa
IT1203901B (it) * 1987-04-15 1989-02-23 Lisapharma Spa Composizioni farmaceutiche sotto forma di sospensioni stabili di sucralfato esenti da agenti sospendenti
US5516537A (en) * 1987-04-20 1996-05-14 Fuisz Technologies Ltd. Frozen comestibles
US5387431A (en) 1991-10-25 1995-02-07 Fuisz Technologies Ltd. Saccharide-based matrix
US5456932A (en) * 1987-04-20 1995-10-10 Fuisz Technologies Ltd. Method of converting a feedstock to a shearform product and product thereof
US5422136A (en) * 1987-04-20 1995-06-06 Fuisz Technologies Ltd. Starch-based food enhancing ingredient
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
US5709873A (en) * 1988-02-26 1998-01-20 Niels Bukh A/S Method of treating conditions of teeth and their supporting tissue
JP2735559B2 (ja) * 1988-03-02 1998-04-02 中外製薬株式会社 懸濁液
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
FR2657010B1 (fr) * 1990-01-12 1992-05-15 Pf Medicament Composition pharmaceutique sous forme de suspension aqueuse stable a base de sucrafalte et d'une substance anti-acide ainsi que son procede de preparation.
DE4022944A1 (de) * 1990-07-19 1992-01-23 Merck Patent Gmbh Sucralfat-kautablette
CA2090479C (fr) * 1990-08-31 2002-01-15 Kiyoshige Ochi Solution-mere de sucralfate en suspension dans l'eau et sa production
US5196199A (en) * 1990-12-14 1993-03-23 Fuisz Technologies Ltd. Hydrophilic form of perfluoro compounds and method of manufacture
US5268110A (en) * 1991-05-17 1993-12-07 Fuisz Technologies Ltd. Oil removing method
WO1992020330A1 (fr) * 1991-05-17 1992-11-26 Fuisz Technologies Ltd. Nouveau materiau polymere thermoplastique et procede de fabrication associe
US5164379A (en) * 1991-07-15 1992-11-17 Bristol-Myers Company Sucralfate/cyclodextrin complexes
US5576042A (en) 1991-10-25 1996-11-19 Fuisz Technologies Ltd. High intensity particulate polysaccharide based liquids
CA2125579C (fr) * 1991-12-17 2005-06-21 Richard C. Fuisz Composition et methode de traitement et de prevention de l'ulcere
US5427804A (en) * 1992-03-05 1995-06-27 Fuisz Technologies Ltd. Low-fat edible proteins with maltodextrins and low-saturate oils
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
US5288508A (en) * 1992-03-20 1994-02-22 Fuisz Technologies, Ltd. Delivery systems containing elastomer solvents subjected to flash flow
US5728397A (en) * 1992-05-12 1998-03-17 Fuisz Technologies Ltd. Polydextrose product and process
CA2095776C (fr) * 1992-05-12 2007-07-10 Richard C. Fuisz Compositions a base de polydextrose, facilement dispersables
US5279849A (en) * 1992-05-12 1994-01-18 Fuisz Technologies Ltd. Dispersible polydextrose, compositions containing same and method for the preparation thereof
US5348758A (en) * 1992-10-20 1994-09-20 Fuisz Technologies Ltd. Controlled melting point matrix formed with admixtures of a shearform matrix material and an oleaginous material
US5380473A (en) * 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
US5518551A (en) * 1993-09-10 1996-05-21 Fuisz Technologies Ltd. Spheroidal crystal sugar and method of making
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5597416A (en) * 1993-10-07 1997-01-28 Fuisz Technologies Ltd. Method of making crystalline sugar and products resulting therefrom
US5851553A (en) * 1993-09-10 1998-12-22 Fuisz Technologies, Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5346377A (en) * 1993-10-07 1994-09-13 Fuisz Technologies Ltd. Apparatus for flash flow processing having feed rate control
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US6020002A (en) * 1994-06-14 2000-02-01 Fuisz Technologies Ltd. Delivery of controlled-release system(s)
US5445769A (en) * 1994-06-27 1995-08-29 Fuisz Technologies Ltd. Spinner head for flash flow processing
US5582855A (en) * 1994-07-01 1996-12-10 Fuisz Technologies Ltd. Flash flow formed solloid delivery systems
US5843922A (en) * 1994-07-29 1998-12-01 Fuisz Technologies Ltd. Preparation of oligosaccharides and products therefrom
US5556652A (en) 1994-08-05 1996-09-17 Fuisz Technologies Ltd. Comestibles containing stabilized highly odorous flavor component delivery systems
EP0808629A4 (fr) * 1995-02-02 1998-03-04 Chugai Pharmaceutical Co Ltd Preparation de sucralfate
US5587198A (en) 1995-05-31 1996-12-24 Fuisz Technologies Ltd. Positive hydration method of preparing confectionery and product therefrom
WO1997028823A1 (fr) * 1996-02-08 1997-08-14 Chugai Seiyaku Kabushiki Kaisha Procede d'utilisation d'un agent antiacide et preparation pharmaceutique le contenant
WO2010048981A1 (fr) * 2008-10-27 2010-05-06 Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.P.A. Compositions pharmaceutiques pouvant être pulvérisées comprenant un gel de sucralfate pour traiter des lésions de la peau ou d'une muqueuse
ITMI20102366A1 (it) * 2010-12-22 2012-06-23 Italiano Biochimico Far Maceutico Lisa Lab Composizioni farmaceutiche spruzzabili per applicazione topica comprendenti gel di sucralfato
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
JP6365236B2 (ja) * 2014-10-28 2018-08-01 ライオン株式会社 ミクロゲル製剤及びその製造方法
JP6365325B2 (ja) * 2015-01-28 2018-08-01 ライオン株式会社 製剤及びその製造方法
EP3352738B1 (fr) 2015-09-24 2024-01-17 The Brigham and Women's Hospital, Inc. Compositions mucoadhésives activées par l'eau pour réduire l'absorption intestinale de nutriments
CN116763728A (zh) * 2022-03-11 2023-09-19 北京阳光诺和药物研究股份有限公司 一种中和胃酸药物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692898A (en) * 1970-11-05 1972-09-19 Sterling Drug Inc Aqueous magnesium hydroxide suspensions
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
GB2090134A (en) * 1980-12-30 1982-07-07 Geistlich Soehne Ed Ag Pharmaceutical Compositions Containing Guaiacol or Derivatives Thereof
GB2120942B (en) * 1982-05-27 1985-10-30 Glaxo Group Ltd Salbutamol compositions
JPS5978116A (ja) * 1982-10-27 1984-05-04 Chugai Pharmaceut Co Ltd スクラルフェ−ト製剤
CA1218601A (fr) * 1983-09-02 1987-03-03 Angel B. Casillan Suspension de sucralfate

Also Published As

Publication number Publication date
PH21250A (en) 1987-08-31
DE3430809A1 (de) 1986-03-06
NO170126B (no) 1992-06-09
NZ213185A (en) 1988-03-30
AU3438284A (en) 1986-03-24
IT8449164A0 (it) 1984-11-14
PT79610A (en) 1985-01-01
DK183386D0 (da) 1986-04-21
ATE41308T1 (de) 1989-04-15
JPH0535130B2 (fr) 1993-05-25
CN85109551A (zh) 1987-05-20
EP0192640B1 (fr) 1989-03-15
SG35889G (en) 1989-10-13
DK164479B (da) 1992-07-06
IE58201B1 (en) 1993-07-28
CA1236773A (fr) 1988-05-17
DK164479C (da) 1992-11-16
ES537578A0 (es) 1986-01-01
EP0192640A1 (fr) 1986-09-03
WO1986001406A1 (fr) 1986-03-13
IT8449164A1 (it) 1986-05-14
IN164763B (fr) 1989-05-27
ES8607727A1 (es) 1986-01-01
AU567257B2 (en) 1987-11-12
ZA848884B (en) 1985-07-31
SU1544173A3 (ru) 1990-02-15
DK183386A (da) 1986-04-21
DE3477138D1 (en) 1989-04-20
IL76138A0 (en) 1985-12-31
IE852058L (en) 1986-02-22
FI80592C (fi) 1990-07-10
FI861674A0 (fi) 1986-04-21
IL76138A (en) 1989-09-28
FI861674L (fi) 1986-04-21
IT1178235B (it) 1987-09-09
NO861545L (no) 1986-04-18
JPS61503031A (ja) 1986-12-25
FI80592B (fi) 1990-03-30
GR852023B (fr) 1985-12-16
NO170126C (no) 1992-09-16
US4885281A (en) 1989-12-05

Similar Documents

Publication Publication Date Title
HK62889A (en) Sucralfate suspension
US4713246A (en) Etoposide oral dosage form
KR910004479B1 (ko) 슈우크럴페이트를 유효성분으로 함유하는 현탁액
US4704278A (en) Fluidized magaldrate suspension
US4623641A (en) Method of treating ulcers and erosions in the gastrointestinal system using PGI2 -methyl ester-beta cyclodextrin inclusion complexes
EP0402933B1 (fr) Utilisation du gel humide de sucralfate comme véhicule pour médicaments à activité topique et pour des produits cosmétiques
US2951011A (en) Silicone composition for the relief of gastro-intestinal distress and method of using same
CA2001044C (fr) Composes pharmaceutiques liquides oraux a base de sulindac
USRE25205E (en) Silicone composition for the relief of
EP0068453A2 (fr) Compositions pour traiter les lithiases rénales
IE790194L (en) Pharmaceutical formulation
CA1238578A (fr) Forme pharmaceutique orale d'etoposide
US4714703A (en) Method of inhibiting herpetic lesions
US2841526A (en) Fatty acid-resin adsorption product
EP0178895B1 (fr) Compositions de magaldrate fluidisées et réhydratables
JPS6330290B2 (fr)
KR930001802B1 (ko) 슈크랄페이트 현탁액의 안정화방법
GB2105988A (en) Anti-platelet aggregation dipyridamole with Al aspirin
CA1252045A (fr) Suspension fluidisee de magaldrate
US4988722A (en) Parenteral compositions
ZA200101153B (en) Transdermally delivered aspirin.
WO1994016695A1 (fr) Composition pharmaceutique contenant de la cimetidine
KR20200142948A (ko) 수용성 활성 약학 성분을 포함하는 시럽제 또는 분말 제제 형태의 경구투여용 약학 조성물

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20040921

PE Patent expired